| |
|
|
|
Redhill Biophrma ADR  
|
|
9.39 -0.43 (-0.04%) |
10-21 16:00 |
|
Open: |
10 |
Pre close: |
9.82 |
Target:
|
12.24 
|
|
High: |
10 |
Low: |
9.26 |
Resistance:
|
10.48
11.24
|
|
Volume: |
262,032 |
Market Cap: |
351M |
Support:
|
9.26
7.70
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
9.94
|
MACD |
MACD(12,26):
|
0.12 |
|
MA(20): |
10.00 |
Signal(12,26,9): |
0.22 |
|
MA(100): |
8.21  |
Stochastic Oscillator |
%K(14,3):
|
35.63 |
|
MA(250): |
6.84 |
%D(3): |
47.40 |
|
Average Volume(K) |
3-Month: |
41489
|
52-Week |
High:
|
11.35 |
|
10-Days: |
31536 |
Low: |
3.26 |
|
RSI |
RSI(14):
|
44.25 |
Change(%): |
50.2 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.640 |
Return on Equity (ttm) |
-164.6 |
Shares Out. (M) |
37.41 |
|
EPS Est. Current Year |
-2.390 |
Return on Assets (ttm) |
-29.6 |
Shares Float (M) |
21.12 |
|
EPS Est. Next Year |
-0.540 |
PEG Ratio |
0.00 |
% Held by Insiders |
15.37 |
|
EPS Est. Next Quarter |
-0.620 |
Qtrly Rev. Growth |
1237.1 |
% Held by Institutions |
20.91 |
|
Forward EPS |
1.700 |
Gross Profit (p.s.) |
0.108 |
Shares Short (K) |
2000 |
|
Book Value (p.s.) |
0.970 |
EBITDA (p.s.) |
-1.301 |
P/E |
-5.73 |
|
Sales Per Share |
0.667 |
Qtrly Earnings Growth |
0.00 |
P/BV |
9.68 |
|
Profit Margin |
-219.39 |
Operating Cash Flow
(M) |
-49.47 |
P/S |
14.08 |
|
Operating Margin |
-204.94 |
Levered Free Cash Flow
(M) |
-82.89 |
P/CF |
-7.10 |
|
|
|
|
|
|
